Classification
- Anatomical main groupLAntineoplastic and immunomodulating agents
- Therapeutic subgroupL04
- Pharmacological subgroupL04A
- Chemical subgroupL04AE
- Chemical substanceL04AE03Siponimod
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Serbia
ALIMS · 15 registrations
- Mayzent®0.25mg · film tableta · PredstavniŠTvo Novartis Pharma Services INC. Beograd (Novi Beograd) · 3 entries
- Mayzent®1mg · film tableta · PredstavniŠTvo Novartis Pharma Services INC. Beograd (Novi Beograd)
Canada
Health Canada · 3 registrations
Netherlands
CBG-MEB · 3 registrations
At a glance
- ATC code
- L04AE03
- Registers
- 6
- Historical lists
- 2
- Registrations
- 29
- With their own page
- 24
- Companies
- 7
All medicines with Siponimod
Human medicines from every register that match Siponimod by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
35 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Mayzent | United States | 0.25MG BASE, 1MG BASE, 2MG BASE | tablet | Marketed | Novartis |
| Mayzent | European Union | Authorised | Novartis Europharm Limited | ||
| Mayzent 0,25 mg, filmomhulde tabletten | Netherlands | Filmomhulde tablet | Authorised | Novartis Europharm Limited | |
| Mayzent 1 mg, filmomhulde tabletten | Netherlands | Filmomhulde tablet | Authorised | Novartis Europharm Limited | |
| Mayzent 2 mg, filmomhulde tabletten | Netherlands | Filmomhulde tablet | Authorised | Novartis Europharm Limited | |
| Mayzent | Canada | 0.25 MG | Tablet | Marketed | Novartis Pharmaceuticals Canada INC |
| Mayzent | Canada | 2 MG | Tablet | Marketed | Novartis Pharmaceuticals Canada INC |
| Mayzent | Canada | 1 MG | Tablet | Authorised | Novartis Pharmaceuticals Canada INC |
| Mayzent® | Serbia | 0.25mg | film tableta | Authorised | PredstavniŠTvo Novartis Pharma Services INC. Beograd (Novi Beograd) |
| Mayzent® | Serbia | 2mg | film tableta | Authorised | PredstavniŠTvo Novartis Pharma Services INC. Beograd (Novi Beograd) |
| Mayzent® | Serbia | 1mg | film tableta | Authorised | PredstavniŠTvo Novartis Pharma Services INC. Beograd (Novi Beograd) |
| Mayzent® | Serbia | 0.25mg | film tableta | Authorised | PredstavniŠTvo Novartis Pharma Services INC. Beograd (Novi Beograd) |
| Mayzent® | Serbia | 0.25mg | film tableta | Authorised | PredstavniŠTvo Novartis Pharma Services INC. Beograd (Novi Beograd) |
| Mayzent® | Serbia | 0.25mg | film tableta | Authorised | PredstavniŠTvo Novartis Pharma Services INC. Beograd (Novi Beograd) |
| Mayzent® | Serbia | 0.25mg | film tableta | Authorised | PredstavniŠTvo Novartis Pharma Services INC. Beograd (Novi Beograd) |
| Mayzent® | Serbia | 1mg | film tableta | Authorised | PredstavniŠTvo Novartis Pharma Services INC. Beograd (Novi Beograd) |
| Mayzent® | Serbia | 2mg | film tableta | Authorised | PredstavniŠTvo Novartis Pharma Services INC. Beograd (Novi Beograd) |
| Mayzent® | Serbia | 1mg | film tableta | Authorised | PredstavniŠTvo Novartis Pharma Services INC. Beograd (Novi Beograd) |
| Mayzent® | Serbia | 0.25mg | film tableta | Authorised | PredstavniŠTvo Novartis Pharma Services INC. Beograd (Novi Beograd) |
| Mayzent® | Serbia | 0.25mg | film tableta | Authorised | PredstavniŠTvo Novartis Pharma Services INC. Beograd (Novi Beograd) |
| Mayzent® | Serbia | 0.25mg | film tableta | Authorised | PredstavniŠTvo Novartis Pharma Services INC. Beograd (Novi Beograd) |
| Mayzent® | Serbia | 2mg | film tableta | Authorised | PredstavniŠTvo Novartis Pharma Services INC. Beograd (Novi Beograd) |
| Mayzent® | Serbia | 2mg | film tableta | Authorised | PredstavniŠTvo Novartis Pharma Services INC. Beograd (Novi Beograd) |
| Mayzent | Croatia | Marketed | |||
| Mayzent | Saudi Arabia | Authorised | NOVARTIS Pharma Stein AG |